REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/08/2026
Back to search
Official data from USPTO
LIGHTBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LIGHTBIO
ST13
US500000079279617Class
1, 5, 9, 40, 42
Filing
79279617
Registration
6375045
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
06/09/2026
Trademark type
Word
Nice classes
1, 5, 9, 40, 42
Filing date
08/28/2019
Registration date
06/08/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/08/2021
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Hampton TW12 2ER, GB
Examiner
LEVINE, HOWARD B
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
LightBio Limited
Representatives
Rebecca Liebowitz Venable LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparationsenzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in scientific research in the field of agri-biotechnology and nanotechnology; nucleic acids comprising natural and unnatural nucleotides for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing; nucleic acid analogues with organic and inorganic chemicals for laboratory use in labellingimaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for laboratory use in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for laboratory use in creating nanostructures and scaffolds; Nucleic acids comprising natural and unnatural nucleotides for laboratory use; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for laboratory use; composites of nucleic acids or nucleic acid analogues with organic and NAC inorganic chemicals for laboratory use; all the aforesaid goods for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing
Class 5
Vaccines; DNA based vaccines; DNA extractsnucleic acid sequences and chemical reagents for medical use; therapeutic DNAnucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acids comprising natural and unnatural nucleotides for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in labelingimaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in creating nanostructures and scaffolds
Class 9
Scientific apparatus and instrumentsapparatus for amplifying DNAreactors and bioreactors; apparatus for manufacturing DNAreactors and bioreactors; apparatus for processing DNAreactors and bioreactors; electronic componentsnucleic acid analogues in the nature of electric and power wiressemi-conductorstransistorsrectifiersdiodeslight emitting diodes and energy storage systems in the nature of devices for energy storagebatteriesfuel cells configured for energy storageelectrochemical devices configured for energy storageelectrolysers; electric and power wires comprised of nucleic acid composites (NACs) semi-conductorstransistorsrectifiersdiodeslight emitting diodes and energy storage systems in the nature of devices for energy storagebatteriesfuel cells configured for energy storageelectrochemical devices configured for energy storageelectrolyserseach comprised of nucleic acid composites (NACs); labelingimaging and sensing apparatus comprising of nucleic acid composites (NACs) for laboratory and research use; smart materials in the nature of DNA chipsDNA microarrayscomprised of nucleic acid composites; two-dimensional and three-dimensional nucleic acid composites (NACs) in the nature of DNA chipsDNA microarrays for creating nanostructures and scaffolds for use in electronic components and materialselectrical conductors; parts and fittings for all the aforesaid technology and parts and fittings for all the aforesaid goodselectrical cablesdisplay screenstransmitters
Class 40
Chemical treatment of DNA to form DNA extracts; custom manufacture of therapeutic DNA by the manipulation of DNA into DNA extracts or cassettes
Class 42
Scientific and technological services and research and design relating theretochemical and biological analysis and research services; DNA analysis services for scientific research purposes; scientific research and development into the creation of DNA extracts; scientific researchanalysisdesign and development relating to DNA based drugs and therapies; scientific research and development in the fields of gene therapygenetic diagnosticsagri-biotechnology and nanotechnologyall in the field of gene therapy; consultancy relating to the aforesaid services
Publications
History of USPTO decisions and trademark events.
36 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/24/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/28/2021
FIMP
FINAL DISPOSITION PROCESSED
09/28/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/08/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/08/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/23/2021
PUBO
PUBLISHED FOR OPPOSITION
03/23/2021
GPNX
NOTIFICATION PROCESSED BY IB
03/21/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/16/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/16/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/16/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/16/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/16/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/11/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/11/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/07/2021
GNFR
FINAL REFUSAL E-MAILED
01/07/2021
CNFR
FINAL REFUSAL WRITTEN
01/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/17/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/17/2020
ALIE
ASSIGNED TO LIE
12/15/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/21/2020
RFNT
REFUSAL PROCESSED BY IB
04/10/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/25/2020
RFRR
REFUSAL PROCESSED BY MPU
03/25/2020
MAFR
APPLICATION FILING RECEIPT MAILED
03/06/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/04/2020
CNRT
NON-FINAL ACTION WRITTEN
03/03/2020
DOCK
ASSIGNED TO EXAMINER
03/02/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/27/2020
Continuous trademark protection
Get notified about every new filing that threatens LIGHTBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.